1. Home
  2. TMDX vs EROK Comparison

TMDX vs EROK Comparison

Compare TMDX & EROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$83.33

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

EROK

EagleRock Land LLC Class A shares representing limited liability company interests

N/A

Current Price

$23.14

Market Cap

2.6B

Sector

Energy

ML Signal

N/A

Company Overview

Basic Information
Metric
TMDX
EROK
Founded
1998
N/A
Country
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.6B
IPO Year
2019
2026

Fundamental Metrics

Financial Performance
Metric
TMDX
EROK
Price
$83.33
$23.14
Analyst Decision
Buy
Analyst Count
9
0
Target Price
$148.22
N/A
AVG Volume (30 Days)
937.7K
125.9K
Earning Date
05-05-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
382.18
N/A
EPS
0.61
N/A
Revenue
$605,494,000.00
N/A
Revenue This Year
$24.25
N/A
Revenue Next Year
$18.75
N/A
P/E Ratio
$131.49
N/A
Revenue Growth
37.13
N/A
52 Week Low
$60.11
$20.06
52 Week High
$156.00
$23.60

Technical Indicators

Market Signals
Indicator
TMDX
EROK
Relative Strength Index (RSI) 58.69 62.02
Support Level $66.18 $20.26
Resistance Level $140.79 N/A
Average True Range (ATR) 4.14 1.06
MACD 0.63 0.13
Stochastic Oscillator 79.36 85.32

Price Performance

Historical Comparison
TMDX
EROK

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: